Development of outcome measures for autoimmune dermatoses.

Development of outcome measures for autoimmune dermatoses.

Item
http://www.wikidata.org/entity/Q36994240
Modification of the cutaneous dermatomyositis disease area and severity index, an outcome instrument.Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.The development and validation of the treatment of autoimmune bullous disease quality of life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease.Quality of life in dermatomyositis.Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index: characterizing disease severity and assessing responsiveness to clinical change.Evaluation of reliability, validity, and responsiveness of the CDASI and the CAT-BM.Reliability and convergent validity of the cutaneous sarcoidosis activity and morphology instrument for assessing cutaneous sarcoidosis.Validation studies of outcome measures in pemphigus.Guidelines on dermatomyositis--excerpt from the interdisciplinary S2k guidelines on myositis syndromes by the German Society of Neurology.
P2860

Development of outcome measures for autoimmune dermatoses.

Item
http://www.wikidata.org/entity/Q36994240
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Development of outcome measures for autoimmune dermatoses.
@en
type
label
Development of outcome measures for autoimmune dermatoses.
@en
prefLabel
Development of outcome measures for autoimmune dermatoses.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Development of outcome measures for autoimmune dermatoses.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932